1. Home
  2. News
  3. Telix Pharmaceuticals Limited
  4. Q4 2022 Business update to accompany quarterly results
More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Q4 2022 Business update to accompany quarterly results

Jan 17, 2023 at 9:48 PM EST · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Jan 17, 2023 at 9:48 PM EST · 18 pages · English

On 6ix: 6ix.com/news/q4-2022-business-update-to-accompany-quarterly-results

Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20↗

Telix Pharmaceuticals Limited on 6ix

In the deck

  • Telix Pharmaceuticals — Q4 2022 Earnings Presentation18 slidesJan 18, 2023

Story so far

  • Q3 2022 Business Update to accompany quarterly resultsOct 20, 2022

Earlier from Telix Pharmaceuticals

  • Appendix 4C and Activities Report - December 2022 QuarterJan 17, 2023
  • Webcast link correction - JP Morgan Conference PresentationJan 10, 2023
  • ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GUDec 21, 2022
  • Telix Acquires Optimal TracersNov 13, 2022
  • ZIRCON Ph III Imaging Study - Top-Line data presentationNov 6, 2022

Later from Telix Pharmaceuticals

  • Telix Full Year Results and Investor Conference Call DetailsFeb 20, 2023
  • 2022 Full Year Results ReleaseFeb 27, 2023
  • Appendix 4E and 2022 Annual ReportFeb 27, 2023
  • 2022 Full Year Results PresentationFeb 27, 2023
  • FDA approval of expanded indication of Illuccix in the USMar 15, 2023
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer